Parainfluenza infectious disease
MONDO:0100197A disease caused by infection with parainfluenza virus. There are four serotypes which cause respiratory illnesses in children and adults.
Also known as: HPIV infectious disorder, parainfluenza (disorder), parainfluenza infectious disorder, human parainfluenza virus infectious disorder, human parainfluenza viruses infectious disorder
12 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
One shot, three viruses? new vaccine trial targets RSV, hMPV, and PIV3 in seniors
⭐️ VACCINE ⭐️ CompletedThis Phase 1 study tests a new vaccine that aims to protect against three respiratory viruses at once: RSV, hMPV, and PIV3. The trial involves 390 adults aged 60 and older and will check if the vaccine is safe and helps the body produce antibodies. Different combinations and dose…
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
Nasal spray vaccine aims to protect kids from two breathing viruses
⭐️ VACCINE ⭐️ CompletedThis study tested two experimental nasal spray vaccines in 24 children aged 2 to 5 years. The vaccines target two viruses that can cause breathing problems: human metapneumovirus (HMPV) and parainfluenza virus type 3 (HPIV3). The main goal was to see if the vaccines are safe and …
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:07 UTC
-
New combo vaccine targets flu, RSV, and more in early trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested the safety and immune response of new vaccines that combine protection against flu, RSV, hMPV, and PIV3 in healthy adults aged 18 to 49. Participants received a single shot of one of several vaccine formulas. The goal was to see if these combination …
Phase: PHASE1 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:11 UTC